Market Performance of Earthlabs, Inc. (SPOT.V) on 22 April 2026
At 10:49 PM Central Europe on Thursday, 22 April 2026, Earthlabs, Inc. (SPOT.V) closed at CAD 0.24, reflecting a decline of 2 % over the preceding 24‑hour period. The company’s shares remain highly liquid, with an outstanding supply of 141.1 million units and a market capitalization of CAD 35.3 million. During the same window, approximately CAD 17.5 k of trading volume was recorded, underscoring modest liquidity relative to the company’s market cap.
A technical snapshot reveals that the 200‑day simple moving average sits at CAD 0.34, suggesting that the current price is trading below a long‑term trend line. Historically, Earthlabs’ price trajectory has been volatile: the highest valuation in the past 52 weeks was CAD 0.68 (recorded 28 January 2026), while the lowest was CAD 0.22 (11 November 2025). Since the close of the previous month, the stock has fallen by 16.95 %, a cumulative decline that signals continued downside pressure in a broader sectoral context.
Strategic Highlights from “Inside the Boardroom”
Earthlabs, Inc., the parent company behind the investor‑oriented platform CEO.CA, has leveraged its “Inside the Boardroom” interview series to spotlight emerging ventures in both mining and biotechnology. Recent interviews with GoldInxs Mining Corp. and Marvel Biosciences Corp. illustrate the breadth of Earthlabs’ portfolio and its commitment to fostering innovation.
GoldInxs Mining Corp.
In an interview focused on GoldInxs, Earthlabs detailed the company’s planned drill program aimed at advancing exploration near a prominent mine site in British Columbia. The program is positioned to refine resource estimates and potentially unlock new mineral deposits, aligning with Earthlabs’ overarching strategy of integrating artificial intelligence (AI) to reduce capital risk for Canadian exploration companies.
Marvel Biosciences Corp.
In a separate feature, Earthlabs highlighted Marvel Biosciences’ progress toward initiating human trials for a novel autism therapy. By spotlighting this development on CEO.CA’s financial website and app, Earthlabs underscores its role in connecting investors with high‑impact opportunities in the biotechnology arena—an area that remains underserved in terms of approved treatment options.
Comparative Performance of Related Stocks
The past 24 hours have seen a range of movements among peer companies, offering context for Earthlabs’ performance:
| Company | Symbol | 24‑hour Change | Current Price (CAD) | Market Cap (CAD) |
|---|---|---|---|---|
| Arizona Eagle Mining | AZEM.V | –2.7 % | 0.72 | 41.5 million |
| Sernova Biotherapeutics | SVA.TO | +9.09 % | 0.11 | 41.5 million |
| Rackla Metals | RAK.V | –6.38 % | 0.21 | 42.0 million |
| Dryden Gold | DRY.V | –17.07 % | 0.16 | 41.9 million |
| Orbit Garant Drilling | OGD.TO | +3.54 % | 1.21 | 42.1 million |
While Earthlabs’ decline mirrors the general downward trend seen in several peer mining stocks, the positive swing in Sernova Biotherapeutics and Orbit Garant Drilling suggests that sectoral dynamics remain heterogeneous.
Earthlabs Inc. – Corporate Overview
Earthlabs Inc. positions itself as a technology solutions provider within the materials sector. The company’s core competency lies in the development of AI algorithms tailored to mineral exploration. By applying sophisticated machine‑learning models to geological data, Earthlabs seeks to minimize capital risk for its Canadian clientele, thereby accelerating the discovery and development of new mineral resources.
Through its CEO.CA platform, Earthlabs not only disseminates investment opportunities but also provides a curated narrative that connects emerging ventures to a discerning investor base. The company’s recent outreach to mining and biotechnology firms exemplifies its dual focus on technological innovation and market intelligence.
